It supports gut health, reduces inflammation, and promotes tissue healing helping address the GI side effects most commonly associated with GLP-1 medications
At 20 mg/mL, your 15 mg dose is only 0.75 mL, a comfortable single injection
Scientific Research Review SURPASS Clinical Trial Program (Type 2 Diabetes) The SURPASS program comprised phase III trials evaluating tirzepatide 5, 10, and 15 mg once weekly in patients with type 2 diabetes: SURPASS-1 (monotherapy, n=478): Tirzepatide reduced HbA1c by 1.87% (5 mg), 1.89% (10 mg), and 2.07% (15 mg) vs
Aggregate Analysis Of Semaglutide Using A Biozen dSEC-1 SEC Column By Sujatha Chilakala, Ph.D., and Lucia Geis-Asteggiante, Ph.D
The database utilized for the current study allowed the researchers to consider a wide range of confounding factors that are often absent in other administrative databases
Small, frequent meals that are nutrient-dense can help maintain energy levels without overwhelming the digestive system